172 related articles for article (PubMed ID: 18845436)
1. N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists.
Aissaoui H; Koberstein R; Zumbrunn C; Gatfield J; Brisbare-Roch C; Jenck F; Treiber A; Boss C
Bioorg Med Chem Lett; 2008 Nov; 18(21):5729-33. PubMed ID: 18845436
[TBL] [Abstract][Full Text] [Related]
2. Proline bis-amides as potent dual orexin receptor antagonists.
Bergman JM; Roecker AJ; Mercer SP; Bednar RA; Reiss DR; Ransom RW; Meacham Harrell C; Pettibone DJ; Lemaire W; Murphy KL; Li C; Prueksaritanont T; Winrow CJ; Renger JJ; Koblan KS; Hartman GD; Coleman PJ
Bioorg Med Chem Lett; 2008 Feb; 18(4):1425-30. PubMed ID: 18207395
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats.
Whitman DB; Cox CD; Breslin MJ; Brashear KM; Schreier JD; Bogusky MJ; Bednar RA; Lemaire W; Bruno JG; Hartman GD; Reiss DR; Harrell CM; Kraus RL; Li Y; Garson SL; Doran SM; Prueksaritanont T; Li C; Winrow CJ; Koblan KS; Renger JJ; Coleman PJ
ChemMedChem; 2009 Jul; 4(7):1069-74. PubMed ID: 19418500
[TBL] [Abstract][Full Text] [Related]
4. Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists.
Stasi LP; Artusi R; Bovino C; Buzzi B; Canciani L; Caselli G; Colace F; Garofalo P; Giambuzzi S; Larger P; Letari O; Mandelli S; Perugini L; Pucci S; Salvi M; Toro P
Bioorg Med Chem Lett; 2013 May; 23(9):2653-8. PubMed ID: 23535328
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists.
Fujimoto T; Kunitomo J; Tomata Y; Nishiyama K; Nakashima M; Hirozane M; Yoshikubo S; Hirai K; Marui S
Bioorg Med Chem Lett; 2011 Nov; 21(21):6414-6. PubMed ID: 21917455
[TBL] [Abstract][Full Text] [Related]
6. Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists.
McAtee LC; Sutton SW; Rudolph DA; Li X; Aluisio LE; Phuong VK; Dvorak CA; Lovenberg TW; Carruthers NI; Jones TK
Bioorg Med Chem Lett; 2004 Aug; 14(16):4225-9. PubMed ID: 15261275
[TBL] [Abstract][Full Text] [Related]
7. Novel pyrazolo-tetrahydropyridines as potent orexin receptor antagonists.
Sifferlen T; Boss C; Cottreel E; Koberstein R; Gude M; Aissaoui H; Weller T; Gatfield J; Brisbare-Roch C; Jenck F
Bioorg Med Chem Lett; 2010 Mar; 20(5):1539-42. PubMed ID: 20144866
[TBL] [Abstract][Full Text] [Related]
8. Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.
Di Fabio R; Pellacani A; Faedo S; Roth A; Piccoli L; Gerrard P; Porter RA; Johnson CN; Thewlis K; Donati D; Stasi L; Spada S; Stemp G; Nash D; Branch C; Kindon L; Massagrande M; Poffe A; Braggio S; Chiarparin E; Marchioro C; Ratti E; Corsi M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5562-7. PubMed ID: 21831639
[TBL] [Abstract][Full Text] [Related]
9. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists.
Coleman PJ; Schreier JD; McGaughey GB; Bogusky MJ; Cox CD; Hartman GD; Ball RG; Harrell CM; Reiss DR; Prueksaritanont T; Winrow CJ; Renger JJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2311-5. PubMed ID: 20207138
[TBL] [Abstract][Full Text] [Related]
11. Orexin receptor antagonists: a review of promising compounds patented since 2006.
Coleman PJ; Renger JJ
Expert Opin Ther Pat; 2010 Mar; 20(3):307-24. PubMed ID: 20180618
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationship studies, and identification of novel 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 1.
Sifferlen T; Koberstein R; Cottreel E; Boller A; Weller T; Gatfield J; Brisbare-Roch C; Jenck F; Boss C
Bioorg Med Chem Lett; 2013 Apr; 23(7):2212-6. PubMed ID: 23434414
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
Malherbe P; Borroni E; Pinard E; Wettstein JG; Knoflach F
Mol Pharmacol; 2009 Sep; 76(3):618-31. PubMed ID: 19542319
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
[TBL] [Abstract][Full Text] [Related]
15. Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding.
Cox CD; McGaughey GB; Bogusky MJ; Whitman DB; Ball RG; Winrow CJ; Renger JJ; Coleman PJ
Bioorg Med Chem Lett; 2009 Jun; 19(11):2997-3001. PubMed ID: 19406641
[TBL] [Abstract][Full Text] [Related]
16. Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists.
Fujimoto T; Tomata Y; Kunitomo J; Hirozane M; Marui S
Bioorg Med Chem Lett; 2011 Nov; 21(21):6409-13. PubMed ID: 21924608
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomnia.
Winrow CJ; Gotter AL; Cox CD; Tannenbaum PL; Garson SL; Doran SM; Breslin MJ; Schreier JD; Fox SV; Harrell CM; Stevens J; Reiss DR; Cui D; Coleman PJ; Renger JJ
Neuropharmacology; 2012 Feb; 62(2):978-87. PubMed ID: 22019562
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat.
Coleman PJ; Schreier JD; Roecker AJ; Mercer SP; McGaughey GB; Cox CD; Hartman GD; Harrell CM; Reiss DR; Doran SM; Garson SL; Anderson WB; Tang C; Prueksaritanont T; Winrow CJ; Renger JJ
Bioorg Med Chem Lett; 2010 Jul; 20(14):4201-5. PubMed ID: 20610153
[TBL] [Abstract][Full Text] [Related]
19. Orexin type 1 receptor antagonist SB 334867 inhibits the central histamine-induced resuscitating effect in rats subjected to haemorrhagic shock.
Jochem J
Inflamm Res; 2009 Apr; 58 Suppl 1():36-7. PubMed ID: 19271123
[No Abstract] [Full Text] [Related]
20. 2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonists.
Micheli F; Antolini M; Di Fabio R; Pellacani A; Pozzan A
Bioorg Med Chem Lett; 2010 Nov; 20(22):6405-7. PubMed ID: 20933413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
